GB201519644D0 - Therapy and pharmaceutical composition - Google Patents

Therapy and pharmaceutical composition

Info

Publication number
GB201519644D0
GB201519644D0 GBGB1519644.7A GB201519644A GB201519644D0 GB 201519644 D0 GB201519644 D0 GB 201519644D0 GB 201519644 A GB201519644 A GB 201519644A GB 201519644 D0 GB201519644 D0 GB 201519644D0
Authority
GB
United Kingdom
Prior art keywords
therapy
pharmaceutical composition
pharmaceutical
composition
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1519644.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Southampton
Original Assignee
University of Southampton
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of Southampton filed Critical University of Southampton
Priority to GBGB1519644.7A priority Critical patent/GB201519644D0/en
Publication of GB201519644D0 publication Critical patent/GB201519644D0/en
Priority to PCT/GB2016/053418 priority patent/WO2017077307A1/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
GBGB1519644.7A 2015-11-06 2015-11-06 Therapy and pharmaceutical composition Ceased GB201519644D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1519644.7A GB201519644D0 (en) 2015-11-06 2015-11-06 Therapy and pharmaceutical composition
PCT/GB2016/053418 WO2017077307A1 (en) 2015-11-06 2016-11-03 Therapy and pharmaceutical composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1519644.7A GB201519644D0 (en) 2015-11-06 2015-11-06 Therapy and pharmaceutical composition

Publications (1)

Publication Number Publication Date
GB201519644D0 true GB201519644D0 (en) 2015-12-23

Family

ID=55132420

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1519644.7A Ceased GB201519644D0 (en) 2015-11-06 2015-11-06 Therapy and pharmaceutical composition

Country Status (2)

Country Link
GB (1) GB201519644D0 (en)
WO (1) WO2017077307A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR120799A1 (en) * 2019-12-20 2022-03-16 Hoffmann La Roche 2-[4-CHLORO-6-[2-[4-[[4-(HYDROXYMETHYL)-1-PIPERIDYL]METHYL]PHENYL]ETHYNYL]-1-OXOISOINDOLIN-2-IL]-2-(6,7- DIHYDRO-5H-PYRROLO[1,2-C]IMIDAZOL-1-IL)-N-TIAZOL-2-IL-ACETAMIDE AS EGFR INHIBITOR
CN113045475A (en) * 2019-12-27 2021-06-29 上海泓博智源医药股份有限公司 Preparation method of 5-bromo-7-methylindole

Also Published As

Publication number Publication date
WO2017077307A1 (en) 2017-05-11

Similar Documents

Publication Publication Date Title
HK1247614A1 (en) Therapeutic compounds and uses thereof
HK1249103B (en) Polycyclic-carbamoylpyridone compounds and their pharmaceutical use
IL258931A (en) Therapeutic compounds and methods
HK1251153A1 (en) Pharmaceutical composition and application thereof
IL259246A (en) Compositions of therapeutic substances, methods and uses thereof
HK1232137A1 (en) Therapeutic compounds and compositions
IL258997B (en) Honey-cannabinoid therapeutic composition
HK1252026A1 (en) Pharmaceutical combination and uses thereof
IL252967A0 (en) Pharmaceutical composition comprising plasminogen and uses thereof
HK1258704A1 (en) Drug composition and coating
PT3513809T (en) Medicinal composition
HK1248697A1 (en) Therapeutic compounds and uses thereof
GB201511382D0 (en) Novel compounds and their use in therapy
ZA201802256B (en) Compounds and therapeutic uses thereof
ZA201601656B (en) Inhalable pharmaceutical composition
HK1245086A1 (en) Pharmaceutical composition preparation and uses thereof
IL255530A (en) Efflux-pump inhibitors and therapeutic uses thereof
ZA201703398B (en) Pharmaceutical composition and methods
HK1245085A1 (en) Pharmaceutical composition preparation and uses thereof
GB201506526D0 (en) Medicinal composition
IL263040A (en) Pharmaceutical composition comprising eteplirsen
GB201406172D0 (en) Therapy and pharmaceutical composition
HK1245113A1 (en) Pharmaceutical compositions and use thereof
GB201519644D0 (en) Therapy and pharmaceutical composition
HUE057830T2 (en) Pharmaceutical composition comprising famitinib

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)